Skin Analytics

Skin Analytics develops autonomous AI medical devices for skin cancer detection.

London, UK—Founded 2012—Website

£19.0MTotal raised

Skin Analytics is a British healthtech company that develops autonomous AI medical devices for skin cancer detection. Its technology is deployed across multiple NHS sites to triage referrals and alleviate specialist shortages.

Founders

Neil Daly

Founder and CEO

Neil is the chief executive officer and founder of Skin Analytics, alongside holding a role on the technology working group for the national commission into the regulation of AI in healthcare at the Medicines and Healthcare products Regulatory Agency. He also brings prior business development experience from Visa.

Investors

Series B16 April 2025
£15.0M
IG
Intrepid Growth PartnersLead
Series A8 September 2020
£4.0M
Hoxton VenturesLead
N
Nesta
MS
Mustard Seed Ventures

Funding history

Series B16 April 2025

£15.0M

Skin Analytics raises £15m in Series B funding led by Intrepid Growth Partners to expand its AI dermatology technology globally.

The Series B round was led by Intrepid Growth Partners and will support international expansion and product development.

Series A8 September 2020

£4.0M

Skin Analytics raises £4m Series A funding from Hoxton Ventures to expand NHS and international operations

Hoxton Ventures led the Series A round with backing from Nesta and Mustard Seed Ventures.